Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By activating these receptors, https://alexiaykpx951530.bloguerosa.com/35080935/retatrutide-a-promising-new-treatment-for-obesity